For veterinary use only.
The recommended starting dose of furosemide for dogs and cats is 40 mg/kg body weight once daily. The dose may be increased to 80 to 90 mg/kg body weight in cases of acute kidney injury, and 40 to 80 mg/kg body weight/day for dogs and cats once daily in cases of acute renal failure, depending on the clinical condition and response.
Side effects
Common side effects may include vomiting, diarrhoea, increased appetite, loss of appetite, lethargy, increased heart rate, coma, increased perspiration, increased blood pressure and respiratory depression (primarily seizures).
Less common but more serious side effects may include skin rashes (frequency of which may occur at the injection site), decreased heart rate and breathing difficulties, or skin discolouration and increased electrolyte disturbances (see also section 3.4). If these serious side effects occur, immediate medical attention should be sought.
If side effects persist or worsen, contact your veterinarian immediately.
Dogs and Cats
Furosemide is a loop diuretic which is used to treat fluid loss caused by congestive heart failure in dogs and cats. Furosemide is available in tablet form and is usually given once a day at the same time.
Please note:This medicine contains furosemide and is not recommended for use in animals with a history of kidney problems or allergy to furosemide. Your veterinarian may prescribe this product for you based on many factors, including your age, weight, other medical conditions (such as diabetes, hypertension, and renal disease), any other medications you are taking, and any other medications you are currently taking.
Please note: This product contains sodium chloride, which may cause dehydration and electrolyte imbalance. If your pet has vomiting, diarrhea, confusion, or heart failure symptoms after taking this medicine, please contact your veterinarian. In the event of a fluid retention or electrolyte imbalance, please contact your veterinarian.
Common side effects may include vomiting, diarrhoea, increased appetite, loss of appetite, lethargy, increased heart rate, coma, increased perspiration, increased heart rate and breathing difficulties (primarily seizures).
Less common side effects may include skin rashes (frequency of which may occur at the injection site), decreased heart rate and breathing difficulties (frequency of which may occur at the injection site), skin discolouration and increased electrolyte disturbances (see also section 3.4), and respiratory depression (primarily seizures).
Read moreCats/ DogsThis product contains sodium chloride, which may cause dehydration and electrolyte imbalance. In dogs and cats, this product may be given at the same time daily.
The recommended starting dose of furosemide for cats is 40 mg/kg body weight once daily. The dose may be increased to 80 to 90 mg/kg body weight in cases of acute kidney injury, and 40 to 80 mg/kg body/day for dogs and cats once daily in cases of acute renal failure, depending on the clinical condition and response.
The dose may be given every 4 to 6 hours, with daily feeding as required. In severe cases, the dose may be given in divided doses. Cats are often dehydrated, and electrolyte imbalance may cause this.
This product contains sodium chloride, which may cause electrolyte imbalance.
1. KD. Tripathi. Diuretics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 579-581.
2. Robert F. Reilley and Edwin K. Jackson. Regulation of renal function and vascular volume. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 682-686.
3. University of Pennsylvania. Furosemide for Accelerated Recovery of Blood Pressure Postpartum (ForBP). NIH U. S. National Library of Medicine ClinicalTrials.gov. [Revised in September 2020] [Accessed on 12th February 2021]https://clinicaltrials.gov/ct2/show/NCT03556761
4, Maria Rosa Ballester, Eulalia Roig, Ignasi Gich, Montse Puntes, Joaquin Delgadillo, Benjamin Santos and Rosa Maria Antonijoan. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure. NCBI; PMC US National Library of Medicine, National Institute of Health. August 2015. [Accessed on 12th February 2021]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532344/
5. Elara Pharmaservices Limited. Electronic Medicines Compendium (EMC). [Revised in October 2020] [Accessed on 12th February 2021]https://www.medicines.org.uk/emc/files/pil.12129.pdf
6. Clonmel Healthcare Ltd. Health Products Regulatory Authority (HPRA). [Revised in December 2016] [Accessed on 12th February 2021]https://www.hpra.ie/img/uploaded/swedocuments/2188112. PA0126_008_002.fbf0465a-d44d-4c59-b51b-337dd8586c8e.000001Product%20Leaflet%20Approved.170215.pdf
Midlands Authority for Regulatory Monitoring and Enforcement. Electronic Enforcement Data Service. [Revised in November 2018] [Accessed on 12th February 2021]https://www.ebsc.gov.uk/ regulatory/e-data Health Products and Medicines Quality Assurance. Electronic Medicines Compendium. [Revised in September 2016]false Zones Control Units. Electronic the Community. [Revised in December 2016]1Electronic The Community.https://www.ebsc.gov.uk/ access/20161212/14/1415029.e4
The National Institute for Health Care Research. National Institute for Health Care Research (N==).https://www. NIHR. T121248
4. [Revised in September 2016] [Accessed on 12th February 2021]MED. NN. NNPhC.
The Royal College of Pharmaceutical Research and Development. Electronic regulatory summary for the United States.royalty-org. R1282
https://www.nih.gov. [Accessed on 12th February]
7. The Electronic Medicines Compendium (EMC). [Revised in September 2016] [Accessed on 12th February]https://www.media.ie/wp-content/uploads andDirected by The National Institute for Health - Institute for Clinical Excellence
The Nervous system.8.
Furosemide is a diuretic commonly used for treating fluid retention (edema) caused by conditions like heart failure, liver disease, or kidney disease. Furosemide tablets offer relief by increasing the urine output and removing excess fluid. Furosemide tablets are available in the brand Lasix 40mg tablets, which makes it convenient to take the medication. It's important to note that furosemide tablets should only be taken under the guidance of a healthcare professional and to be used as directed. It's also important to note that the medication should be stored at room temperature, and it's always recommended to store it away from the reach of children.
Furosemide tablets are designed to be taken in the correct dosages to provide effective and safe results. Furosemide tablets can be taken with or without food, but consistency in water dosage will be key. If symptoms persist, please consult your doctor to determine the proper dosage. It's important to note that furosemide tablets should only be used under the guidance of a healthcare professional, as they can determine the appropriate dosage for you. They will be able to advise you on the most appropriate course of action for your condition.
Furosemide tablets are not effective for everyone. It's best to consult with a healthcare professional before starting any new medication. If you have any questions or concerns, your healthcare provider will be happy to assist with any necessary changes.
Furosemide tablets have a low risk of drowsiness. However, if you experience dizziness, tiredness, or weakness, consult your doctor immediately. The medication should be used with caution in children under the age of 8. It's important to follow the instructions provided by your healthcare provider and to use this medication under the guidance of a healthcare professional.
Furosemide tablets are designed to be taken with or without food. However, it is always recommended to take the medication only as directed. It's also important to follow the instructions provided by your healthcare provider and to use this medication under the guidance of a healthcare professional.
Furosemide tablets are not suitable for everyone.
Show LessReferences| | | | | | | | | | | | | | | | | |Furosemide tabletTablets|
Furosemide is a commonly prescribed medication used to treat fluid retention (edema) caused by conditions like heart failure, liver disease, or kidney disease. It's important to note that furosemide tablets should only be used under the guidance of a healthcare professional and to be used as directed.
If symptoms persist, please consult your doctor to determine the appropriate dosage.
Furosemide 40mg Tablets
Manufactured by the University of Texas M. D. Anderson Cancer Center in Houston, this oral diuretic has been clinically proven to reduce the frequency and severity of hypertension in patients. It is administered by IV infusion through a catheter that is inserted through the bladder and the proximal end of the abdomen. The drug is given as a bolus once daily. The patient is administered the tablet at a rate of 10 to 20 mg/hr. The drug is given by IV infusion through a catheter that is inserted through the rectum and the rectal or bladder. The drug is given by subcutaneous infusion through an infusion catheter that is inserted through the abdomen and the rectum. The drug is given by subcutaneous infusion through an infusion catheter that is inserted through the rectal or bladder.
The drug is administered by subcutaneous infusion through an infusion catheter that is inserted through the abdomen and the rectum. The drug is administered by subcutaneous infusion through an infusion catheter that is inserted through the rectal or bladder.
It is administered by IV infusion through a catheter that is inserted through the rectum and the rectal or bladder. The drug is given by IV infusion through a catheter that is inserted through the abdomen and the rectum.
This study is a randomised controlled trial (RCT) in which the primary objective is to investigate the safety and tolerability of furosemide, a diuretic that is used to manage congestive heart failure.
A randomised controlled trial (RCT) was conducted in which the primary objective is to investigate the safety and tolerability of furosemide, a diuretic that is used to manage congestive heart failure.
The primary objectives of the study were to:
Patients with NYHA Class IV heart failure were randomised to receive either furosemide 400 mg twice daily (n = 15) or furosemide placebo (n = 15) at week 12 or at week 16. The primary efficacy variable was the proportion of patients that met the following criteria:
Symptomatic or acute NYHA Class IV heart failure
Symptomatic or acute NYHA Class V heart failure
Symptomatic or acute NYHA Class IV heart failure at week 12 or at week 16
Patients with NYHA Class IV heart failure were randomised to one of the following groups:
Group 1: furosemide 400 mg twice daily (n = 15) followed by placebo (n = 15) at week 12
Group 2: furosemide placebo followed by placebo at week 16
The secondary efficacy variables were the number of patients with NYHA Class IV or V heart failure and the frequency of patients achieving NYHA Class IV or V heart failure at week 12 or at week 16.
Patients were assigned a random sequence of random number by the investigators or by an anonymous clinician at the Hospital of the First Military Medical University. All patients were randomized to receive either furosemide 400 mg twice daily (n = 15) or furosemide placebo (n = 15) at week 12 or at week 16. The primary efficacy variable was the number of patients that met the following criteria:
Group 1: furosemide 400 mg twice daily (n = 15) followed by placebo (n = 15) at week 12 or at week 16
The study was conducted with a single-blinded, randomised, double-dummy, placebo-controlled study (RCT) conducted in which patients were randomly assigned to receive either furosemide 400 mg twice daily (n = 15) or furosemide placebo (n = 15) at week 12 or at week 16.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
HealthylifeHealthcareylife.com.au offersHealthylife productsHealthylife contains this product:
Stade de France Pharmacy